Yassin Taher/ LinkedIn
May 29, 2026, 09:53
Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
Yassin Taher, Pediatric Oncology Consultant at Children’s Cancer Hospital, shared a post on LinkedIn:
“Pediatric Hypereosinophilic Syndrome (HES) can mimic infection, autoimmune disease, lymphoma, or primary immunologic disorders.
I created this high-yield visual summary to simplify:
- Classification
- Diagnostic approach
- Molecular testing
- Organ involvement
- Modern targeted therapies
Key takeaway: Always evaluate persistent eosinophilia with evidence of organ dysfunction for possible clonal eosinophilic disorders, particularly FIP1L1–PDGFRA–associated disease due to its dramatic response to imatinib.”
Stay updated with Hemostasis Today.
-
Aug 31, 2026, 05:35Does LDL Cholesterol Influence VTE Risk? – Ordo Fraterna Fibonacci
-
Aug 31, 2026, 05:19Tania Ahuja: Apixaban in Abdominal Transplant Patients
-
Aug 31, 2026, 04:28Reza Hafidz Irawan։ Automated Antibody Titration With Erytra Eflexis
-
Aug 31, 2026, 04:17Safa Chenganath: Stenosis vs Thrombosis – Hemodialysis Vascular Access
-
Aug 30, 2026, 17:13J. Meireles-Brandao: Hypertension, Inflammation and Lipoprotein Disease
-
Aug 30, 2026, 17:10Hugh Nguyen: Leading the New Era of Blood Services Across Asia Pacific
-
Aug 30, 2026, 17:09Transforming Childhood Through Access to Hemophilia Treatment – World Federation of Hemophilia
-
Aug 30, 2026, 17:07Raj Bharath: Connecting Clinicians and Researchers to Advance Transfusion Medicine
-
Aug 30, 2026, 17:04Rana Al Hrout: Free FRCPath Haematology Part 1 Exam Preparation Session